Customized Contrast Media Dose Clinical Trial

NATerminatedINTERVENTIONAL
Enrollment

166

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

October 6, 2016

Study Completion Date

October 6, 2016

Conditions
CT of the Abdomen and Pelvis With Contrast Material
Interventions
DRUG

Iopamidol

Iopamidol is the contrast material being used for this study. 100 subjects will receive a fixed dose and rate (150 mL of iopamidol with a concentration of 300 mg of iodine/mL at an injection rate of 3 mL/sec for a total dose of 45 grams of iodine) and 400 subjects will be administered a customized dose and rate (X mL of iopamidol with a concentration of 300 mg of iodine/mL at an injection rate of X mL/sec for a total dose of X grams of iodine).

DEVICE

Mydose

400 subjects will receive a customized dose of contrast material (iopamidol) based on the experimental algorithm Mydose using a combination of subject parameters.

Trial Locations (1)

27713

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Nemoto Kyorindo Co, Ltd.

UNKNOWN

lead

Duke University

OTHER